Welcoming the German Pharmaceutical and Biotechnology Delegation to Australia
We are thrilled to welcome a delegation of five German companies in the pharmaceutical and biotechnology industries and in laboratory technology to Australia at the end of June 2024. The delegation as part of the Healthcare Industry Export Initiative, sponsored by the Federal Ministry of Economic Affairs and Climate Action (BMWK), aims to bolster collaboration between German enterprises specializing in pharmaceuticals, biotechnology, and laboratory technology, and the burgeoning Australian market.
About the Event:
Our delegation is geared towards facilitating concrete business engagements with potential partners in Sydney and Melbourne, the vibrant hubs of Australian commerce. As part of this journey, we are organizing an industry conference and networking event in Sydney, offering a platform for the participating companies to showcase their products, technologies, and services to a discerning Australian audience – you!
This gathering welcomes stakeholders from diverse backgrounds - industry, governmental, academic, and research representatives. Your participation and input will be welcome to strengthen and foster collaborations that drive innovation forward.
At this Industry Conference you can expect presentations from our German delegation guests on their innovative products and services and to explore areas of mutual interest between our two countries. You can look forward to insightful company pitches from
CG Pharma & Biotech GmbH
IQVIA Commercial GmbH & Co. OHG
Helixor Heilmittel GmbH
Serum Life Science Europe GmbH
Yumab GmbH
The conference will be complemented with insights into the German pharma and biotech market by Germany Trade and Invest and two expert panels with industry leaders and subject matter experts.
Expertenpanels:
Expert Panel 1: Opportunities and Challenges in Pharmaceuticals and Biotechnology
- Anthony Murray - BioNSW - Founder
- Robyn Lindner - AusBiotech - General Manager NSW
- Dirk Otto - Boehringer Ingelheim - Managing Director
Facilitator: Martin Hayes, Mayes Healthcare – Director
Expert Panel 2: Australia’s Innovation landscape – an outlook for international collaboration
- Antoine van Oijen - Faculty of Medicine & Health, University of Sydney - Associate Dean (Research)
- Katja Beitat – Cicada Innovation - Head of Health Tech
Facilitator: Patrick Haubruck, BellaSeno, VP R&D
We are excited to hear expert insights on the Australian pharmaceutical and biotech market and its innovation landscape.
The event will be completed with networking opportunities to forge invaluable connections with key players in the German Australian pharma and biotech landscape. Engage in fruitful discussions and lay the groundwork for future partnerships that transcend borders.
The conference offers a great chance to connect with the German-Australian health ecosystem, opening doors to new opportunities and paving the way for expansion into one of Europe's most prominent markets.
